Stemtech Corporation (STEK)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Stem Cell Enhancers	4.92M
Stem Cell Enhancers Growth	7.94%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Latin America	3.07M
Latin America Growth	22.54%
United States and Canada	1.68M
United States and Canada Growth	8.33%
Asia	180.27K
Asia Growth	-64.72%